Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

CPPS 337 > Clinical Trial Designs and Evaluation (5&6) > Flashcards

Clinical Trial Designs and Evaluation (5&6) Flashcards

1
Q

Design Issues

A
  1. Primary Question
  2. Study population
  3. Randomization
  4. Blinding
  5. Control Groups
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Every clinical trial has to have a ____ ____. This as well as secondary questions should be selected carefully an clearly defined and stated.

A

Primary Question (can be put into a statement)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Examples of Primary and Secondary questions

A

The outcome may be a clinical event such as improving survival, ameliorating an illness or disease complications, reducing symptoms, or improving quality of life

Modifying an intermediate or surrogate characteristic such as blood pressure; or changing a biomarker such as a laboratory value.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Study population

A

should be defined in advance, stating unambiguous inclusion and exclusion (eligibility) criteria.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

The study population is the _____ of the population with the condition or characteristics of interest defined by the eligibility criteria.

A

subset

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

The trial participants are selected from

A

the study population.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Eligibility for study population

A

relate to participant safety and anticipated effect of the intervention.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

People are chosen (in study population design issue) for whom there is a high likelihood of _____ ____ _____ ___ _ ___ ___ .

Careful choice will allow for detection of results in a reasonable period of time, given a reasonable number of participants and a finite amount of funding.

A

detecting the hypothesized effects of the intervention.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Randomized controlled trials (RCTs)

A

are comparative studies with an intervention group and a control group.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

The randomization procedure ______ assigns the participant to one group or the other.

A

randomly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Random assignment to treatment is only ethical when there is genuine ____ _____ _______ ______ ___ ____ ____ __ ______

A

uncertainty on the part of the relevant expert community about which therapy is most effective for a given condition (“clinical equipoise”).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Clinical equipois

A

Uncertainty on the part of the relevant expert community about which therapy is most effective for a given condition

RCTS are only given under this condition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Advantages of Randomization:

A
  1. Removal of bias
  2. Comparable groups
  3. Statistical validity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Randomization ____ potential bias in allocating participants to groups

A

removes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Selection bias is

A

due to bias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Bias can easily occur in a ___ ______ ______ because the investigator or the participant may influence the choice of intervention.

A

non-randomized study

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

This influence of bias can be _____ or ________and can be due to numerous factors, including the prognosis of the participant.

A

conscious or subconscious

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Bias

A

Can easily invalidate the trial results.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Comparable groups

Groups that are the same in both known and unknown characteristics

A

Randomization results in groups that are the same for important characteristics (known and unknown).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

In comparable groups we can say the groups being compared tend to be

A

“evenly balanced.”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

An advantage of randomization results in statistical validity

A

The validity of statistical tests of significance is guaranteed.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

If randomization is not used, further assumptions about the comparability of the groups and the appropriateness of the ____________ must be made before the comparisons will be valid.

A

statistical models

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Non randomized clinical trials

A

Establishing the validity of these assumptions may be difficult.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Non-Randomized Control Studies

A

Participants are allocated to one of two (or more) groups, but the allocation is not a random process.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Non-Randomized Control Studies Examples

A
  1. Surgery vs Medical clinical

2. Patient offered two treatments and chooses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

The major weakness of non-randomized control studies is the potential that the

A

intervention group and control group are not strictly comparable (bias).

(We lost comparability and Statistical validity as as well as bias)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

In non randomized control studies, comparisons between groups ___ __ ____, using statistical techniques to adjust for observed baseline imbalances. __ ______ ______ ______

A

Can be made

Regardless, bias is difficult to overcome.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Randomization in review

A

tends to produce study groups comparable with respect to known as well as unknown risk factors, removes investigator bias in the allocation of participants and ensures statistical validity.

29
Q

Bias can be caused by

A

conscious factors, subconscious factors, or both.

30
Q

One solution to the problem of bias is to

A

keep the participants and the investigators blinded, or masked, to the identity of the assigned intervention.

31
Q

Single-Blind:

A

Only the participants are unaware of the treatment (or placebo) they are receiving.

32
Q

Double-Blind:

A

Neither the participants nor the investigators know the identity of the intervention assigned.

33
Q

Ideally, trials should be _____-______ in order to limit potential problems of bias during data collection and assessment.

A

double-blinded

34
Q

Numerous steps must be taken to maintain the blind,

like:

A

e.g., identical tablet appearance and taste, coding of drugs bottles, identical treatment administration.

35
Q

For some trials, e.g., many surgery trials, blinding is __ ______.

A

not feasible.

36
Q

Sound scientific clinical investigation almost always demands that a _____ _____ be used against which the new intervention can be compared.

A

control group

37
Q

Randomization is the preferred way of

A

assigning participants to control and intervention groups.

38
Q

Most trials use the so-called

A

parallel design or concurrent control

39
Q

Parallel design

A

the intervention and control groups are followed simultaneously from the time of allocation to one or the other (concurrent control).

40
Q

Historical control studies

A

these compare a group of participants on a new intervention with a previous group of participants on standard or control therapy.

41
Q

Concurrent (Parallel) Control Studies

A

When both the control and the intervention are doing it at the same time

42
Q

Types of Concurrent (Parallel) Control Studies

A
  1. Cross-over trial (each person is part of both the intervention and control)
  2. Withdrawal study, in which everyone is first on the intervention then half and half
43
Q

(Parallel Control Study)

Participants in the control group may be on

A

placebo, no treatment, usual or standard-of-care, or a specified treatment.

44
Q

Principal difference between placebo and no treatment is that a no-treatment trial is

A

not blinded.

if there is no placebo they know they are receiving nothing thus not blinded

45
Q

Cross-over trial (type of parallel control study)

A

uses each participant at least twice, at least once as a member of the control group and at least once as a member of one or more intervention groups.

46
Q

Withdrawal study (type of parallel control study)

This one is randomized

A

starts with all participants on the active intervention and then, usually randomly, assigns a portion to be followed on the active intervention and the remainder to be followed off the intervention.

47
Q

A placebo is an

A

inactive substance or intervention, such as an inactive tablet or sham surgery, that resembles the comparable active substance or intervention.

48
Q

A new intervention is added to ____ or _______ and compared against that care plus placebo.

A

usual care or standard-of-care and compared against that care

PLUS PLACEBO

49
Q

A placebo ___ ___ ____ ______ if an existing therapy has been proven beneficial (standard-of-care).

A

may not be considered ethical

50
Q

Placebo is not always feasible

A

especially for some surgery and oncology trials

51
Q

Placebo effect

A

The simple act of receiving a treatment (active or not) may, in itself, be efficacious because of an expectation of benefit.

The placebo effect is a potential confounder in assessing the efficacy of any therapeutic intervention.

52
Q

Failed Blinding with Placebo

A

A trial at the National Institutes of Health of the possible benefits of ascorbic acid vs. placebo for the common cold was designed as a double-blind study.

Those in placebo dropped out

Those who knew they were on Ascorbic reported better

Those who didn’t know did not change

53
Q

Cross-Over Designs

A

each participant receives either intervention or control (A or B) in the first period and the alternative in the succeeding period.

54
Q

(In Cross over designs)

Each participant serves as his or her own .

A

control

55
Q

(In Cross over designs)

The order in which A and B are given to each participant is ______.

A

randomized
Thus, approximately half of the participants receive the intervention in the sequence AB and the other half in the sequence BA.

56
Q

Fairly strict assumption must be made about cross over designs:

A

effects of intervention during first period must not carry over into second period. Often can’t be made.

57
Q

(In Cross over designs)

May require ___________ between periods.

A

“wash-out”

58
Q

Withdrawal Studies

A

Participants on a particular treatment (e.g., for a chronic disease) are taken off therapy or have the dosage reduced.

59
Q

(In withdrawal studies)

Objective of these studies is to _____ _______ __ _________ __ _____ _______

A

assess response to discontinuation or dose reduction.

60
Q

(In withdrawal studies)

This design may be validly used to evaluate the _______ of benefit of an intervention already known to be useful.

A

duration

61
Q

In historical control studies

A

a new intervention is used in a series of participants and the results are compared to the outcome in a previous series of comparable participants (e.g., data retrieved from a database).

62
Q

Historical controls are, by definition, ___________.

A

nonrandomized

63
Q

The argument for using a historical control design is that

A

all new participants can receive the new intervention. Many clinicians believe that all participants should have the possibility of receiving a new therapy.

64
Q

Historical control studies are particularly vulnerable to _____.

A

bias

65
Q

An improvement in outcome for a given disease may be attributed to a new intervention when, in fact, the improvement may stem from

A

a change in the patient population or patient management.

66
Q

HCTs (79%) and RCTs (20%)

A

more bias in finding better results of with historical control studies

67
Q

Shown to be harmful through the use of RCTs

A

High-dose oxygen therapy in neonates

Antiarrhythmic drugs after myocardial infarction

Fluoride treatment for osteoporosis

Bed rest in twin pregnancy

Hormone replacement therapy in vascular prevention

Extracranial to intracranial arterial bypass surgery in stroke prevention

High-dose aspirin for carotid endarterectomy

68
Q

Shown to be beneficial through the use of RCTs

A

β blockers in heart failure

Digoxin after myocardial infarction

69
Q

For each clinical trial, a _______ _______ should be carefully selected, clearly defined, and stated in advance.

The _____ ______should be defined in advance, stating unambiguous inclusion and exclusion (eligibility) criteria.

A

primary question

study population

CPPS 337 (3 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions